converting between glp 1 agonists Frontiers Main physiological actions of the
Description
Hydrogen sulfide produced by the gut microbiota impairs host metabolism via reducing GLP-1 levels in male mice

Another study showed that the impact of tirzepatide on weight loss was greater than semaglutide in adults who are overweight or obese, demonstrating different effects in comparison to the breast cancer population [90]

Diabetes Obes Metab 2019;21:4351 [DOI] [PMC free article] [PubMed] [Google Scholar] 63.Hinnen D

GLP-1 specifically binds to the glucagon-like peptide-1 receptor (GLP-1R) in the body, directly stimulating the secretion of insulin by pancreatic -cells, promoting proliferation and differentiation, and inhibiting cell apoptosis, thereby exerting a glycemic lowering effect

But researchers are increasingly seeing signs that some benefits may be weight-independent

Pharmaceutical companies have been trying to produce small-molecule GLP-1 agonists that are shelf-stable and can be taken orallyfor instance, Pfizer and Eli Lilly have developed Danuglipron and Orforglipron, respectivelybut we know very little about how they work, said Ali Gler, a neuroscientist at the University of Virginia
